Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow Reinvestment Rate
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Reinvestment Rate of 0.16x as of December 2025, reinvesting $55.93 Billion (capex $42.57 Billion plus investments $-13.37 Billion) from operating cash flow of $360.04 Billion. See Takeda Pharmaceutical Co Ltd ADR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Co Ltd ADR Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Takeda Pharmaceutical Co Ltd ADR across 26 annual periods. For the full cash flow conversion analysis, see Takeda Pharmaceutical Co Ltd ADR cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year capital reinvestment analysis for Takeda Pharmaceutical Co Ltd ADR. See financial agility of Takeda Pharmaceutical Co Ltd ADR to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $567.86 Billion | $1.06 Trillion | $200.79 Billion | ▼ -59.3% |
| 2024 | 1.32x | $944.59 Billion | $716.34 Billion | $480.73 Billion | ▲ +3.8% |
| 2023 | 1.27x | $1.24 Trillion | $977.16 Billion | $633.69 Billion | ▲ +271.2% |
| 2022 | 0.34x | $384.16 Billion | $1.12 Trillion | $186.04 Billion | ▲ +15.9% |
| 2021 | 0.30x | $298.48 Billion | $1.01 Trillion | $236.47 Billion | ▼ -61.2% |
| 2020 | 0.76x | $509.83 Billion | $669.75 Billion | $217.71 Billion | ▼ -91.6% |
| 2019 | 9.04x | $2.97 Trillion | $328.48 Billion | $134.11 Billion | ▲ +1441.6% |
| 2018 | 0.59x | $221.60 Billion | $377.85 Billion | $128.26 Billion | ▼ -80.0% |
| 2017 | 2.94x | $767.72 Billion | $261.36 Billion | $112.03 Billion | ▼ -11.8% |
| 2016 | 3.33x | $84.86 Billion | $25.49 Billion | $84.86 Billion | ▲ +452.0% |
| 2015 | 0.60x | $110.06 Billion | $182.52 Billion | $108.72 Billion | ▲ +13.9% |
| 2014 | 0.53x | $78.52 Billion | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $95.76 Billion | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $61.90 Billion | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $124.17 Billion | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $86.96 Billion | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $39.46 Billion | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $32.62 Billion | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $29.15 Billion | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $32.09 Billion | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $53.67 Billion | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $54.16 Billion | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $33.48 Billion | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $37.52 Billion | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $26.94 Billion | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $35.42 Billion | $158.96 Billion | $35.42 Billion | — |